Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13425
Title: | Pre-Clinical Investigation of Repaglinide Nanoparticles in High Fat Diet with streptozotocin induced memory impaired rats |
Authors: | Taliyan, Rajeev |
Keywords: | Pharmacy Streptozotocin Repaglinide (REP) |
Issue Date: | Jun-2023 |
Publisher: | Wiley |
Abstract: | Diabetes Mellitus is a metabolic disorder characterized by insulin resistance with several metabolic abnormalities which trigger neuronal complications, neurodegeneration, and cognitive impairments. Repaglinide (REP) is an insulinotropic, neuroprotective agent with short-action and poor absorption characteristics. Hence, the present study was aimed to investigate the efficacy of REP-loaded lipid polymer-hybrid nanoparticles (REP-LPHNPs) in High Fat Diet low dose of Streptozotocin (HFD-STZ) induced cognitive deficits wistar rats model. |
URI: | https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.065550 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13425 |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.